High-Throughput MicroRNA Profiles of Permissive Madin-Darby Canine Kidney Cell Line Infected with Influenza B Viruses.
Canis lupus familiaris
MDCK
Victoria
Yamagata
influenza B viruses
microRNAs
next-generation sequencing
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
25 10 2019
25 10 2019
Historique:
received:
09
09
2019
revised:
15
10
2019
accepted:
23
10
2019
entrez:
14
11
2019
pubmed:
14
11
2019
medline:
2
10
2020
Statut:
epublish
Résumé
Victoria and Yamagata lineages of influenza B viruses are globally circulating in seasonal epidemics. Madin-Darby canine kidney (MDCK) cells are permissive for viral isolation and vaccine manufacture. Nevertheless, the interplay between influenza B viruses and host microRNAs has not been investigated in this cell line. Therefore, the present study aims at high-throughput analysis of canine microRNA profile upon infection of influenza B viruses. Briefly, MDCK cells were infected with Victoria or Yamagata lineage at MOI of 0.01. After being harvested at 6, 12 and 24 h post infection, microRNAs were subjected to high-throughput sequencing based on MiSeq platform (Illumina). The results demonstrated that five microRNAs including cfa-miR-197, cfa-miR-215, cfa-miR361, cfa-miR-1841, and cfa-miR-1842 were overexpressed in both Victoria and Yamagata lineage infections. Interestingly, computational prediction showed that karyopherin alpha 6 (KPNA6) was targeted by cfa-miR-197 and cfa-miR-215. Moreover, the binding sites of both microRNAs were assessed by 3'-UTR reporter assay. The results showed that only cfa-miR-197 could bind to the target sites of KPNA6, leading to suppressing luciferase activity. Additionally, silencing of KPNA6 was confirmed by overexpression of cfa-miR-197. This study provides canine microRNA responses to seasonal influenza B viruses, suggesting that virus-mediated microRNAs might play crucial roles in host gene regulation.
Identifiants
pubmed: 31717720
pii: v11110986
doi: 10.3390/v11110986
pmc: PMC6893747
pii:
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Sci Signal. 2015 Dec 08;8(406):ra126
pubmed: 26645583
RNA. 2004 Oct;10(10):1507-17
pubmed: 15383676
J Virol. 2015 Nov 18;90(3):1424-38
pubmed: 26581983
J Virol. 2015 Sep;89(17):9010-20
pubmed: 26085167
J Virol. 2012 May;86(9):5278-87
pubmed: 22345437
J Med Virol. 2017 Jan;89(1):41-48
pubmed: 27322373
Nucleic Acids Res. 2014 Jan;42(Database issue):D68-73
pubmed: 24275495
Intervirology. 1993;35(1-4):16-25
pubmed: 8407243
Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52
pubmed: 25378301
J Viral Hepat. 2014 Feb;21(2):121-8
pubmed: 24383925
Vaccine. 2002 Aug 19;20(25-26):3068-87
pubmed: 12163258
J Virol. 2015 Mar;89(6):3356-65
pubmed: 25589644
Cytotechnology. 2014 May;66(3):515-23
pubmed: 23912187
Virology. 2014 Nov;468-470:256-264
pubmed: 25203353
J Infect Dis. 2015 Oct 1;212 Suppl 2:S316-21
pubmed: 26185094
Mol Cell Biol. 2011 May;31(9):1800-11
pubmed: 21383067
Front Genet. 2018 Oct 02;9:439
pubmed: 30333857
Vaccine. 2011 Apr 12;29(17):3320-8
pubmed: 21335031
Vaccine. 2018 Jan 2;36(1):107-113
pubmed: 29174679
Yonsei Med J. 2018 Jun;59(4):511-518
pubmed: 29749134
Free Radic Biol Med. 2017 Sep;110:300-315
pubmed: 28673615
Biochem Biophys Res Commun. 2014 Jul 18;450(1):755-61
pubmed: 24953694
J Gen Virol. 2011 Jan;92(Pt 1):1-17
pubmed: 20926635
Am J Pathol. 2017 Apr;187(4):831-840
pubmed: 28189564
J Virol. 2018 Apr 13;92(9):
pubmed: 29444946
J Neuroinflammation. 2015 Feb 18;12:30
pubmed: 25889446
PLoS One. 2012;7(10):e46890
pubmed: 23071657
Mol Med Rep. 2018 Mar;17(3):3921-3927
pubmed: 29286108
Virology. 1990 Mar;175(1):59-68
pubmed: 2309452
Sci Rep. 2017 Dec 7;7(1):17164
pubmed: 29215074
Curr Protoc Microbiol. 2013;Chapter 15:Unit 15G.1
pubmed: 23686827
Viruses. 2017 Nov 25;9(12):
pubmed: 29186842
Arch Virol. 2014 Nov;159(11):2997-3003
pubmed: 25008898
Nat Commun. 2014;5:3344
pubmed: 24561744
Microb Pathog. 2018 Aug;121:252-261
pubmed: 29772263
Trends Mol Med. 2017 Jan;23(1):80-93
pubmed: 27989642
PLoS Pathog. 2008 Feb 8;4(2):e11
pubmed: 18248089
PLoS One. 2012;7(1):e30030
pubmed: 22272270
Structure. 2015 Feb 3;23(2):374-84
pubmed: 25599645
Antiviral Res. 2018 Jun;154:166-173
pubmed: 29656059
Elife. 2015 Aug 12;4:null
pubmed: 26267216
PLoS Pathog. 2012 Jan;8(1):e1002488
pubmed: 22275867
Sci Rep. 2017 Sep 12;7(1):11381
pubmed: 28900157
Exp Biol Med (Maywood). 2016 Feb;241(4):409-20
pubmed: 26518627
J Virol. 2017 Jan 31;91(4):
pubmed: 27974555
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
J Infect. 2013 Oct;67(4):329-41
pubmed: 23685241
Virology. 2013 Dec;447(1-2):84-94
pubmed: 24210102
J Virol. 2014 Jul;88(14):8166-79
pubmed: 24829333
Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1:3-12
pubmed: 26256290
Microrna. 2018;7(3):204-214
pubmed: 29766833
J Immunol. 2012 Dec 15;189(12):5965-75
pubmed: 23169590
Cancer Lett. 2015 Feb 1;357(1):196-205
pubmed: 25444916
Bioessays. 2013 Jan;35(1):23-7
pubmed: 23239226
Nat Rev Genet. 2015 Jul;16(7):421-33
pubmed: 26077373
Oncol Rep. 2016 Mar;35(3):1816-22
pubmed: 26676658
J Virol. 1996 Aug;70(8):5519-24
pubmed: 8764064